Skinvisible Total Assets Growth & History (SKVI)
Skinvisible's total assets was $127,567 for fiscal 2025.
View full Skinvisible company overviewSkinvisible annual total assets history
| Fiscal year | Period ended | Total assets | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $127,567 | −$30,650 | −19.37% |
| 2024 | 2024-12-31 | $158,217 | −$4,652 | −2.86% |
| 2023 | 2023-12-31 | $162,869 | −$83,924 | −34.01% |
| 2022 | 2022-12-31 | $246,793 | $19,494 | +8.58% |
| 2021 | 2021-12-31 | $227,299 | $27,055 | +13.51% |
| 2020 | 2020-12-31 | $200,244 | $18,482 | +10.17% |
| 2019 | 2019-12-31 | $181,762 | −$38,626 | −17.53% |
| 2018 | 2018-12-31 | $220,388 | −$411,801 | −65.14% |
| 2017 | 2017-12-31 | $632,189 | $292,592 | +86.16% |
| 2016 | 2016-12-31 | $339,597 | −$60,933 | −15.21% |
| 2015 | 2015-12-31 | $400,530 | −$245,524 | −38.00% |
| 2014 | 2014-12-31 | $646,054 | −$227,997 | −26.09% |
| 2013 · Dec 31 | 2013-12-31 | $874,051 | $119,804 | +15.88% |
| 2012 | 2012-12-31 | $754,247 | $457,330 | +154.03% |
| 2011 | 2011-12-31 | $296,917 | $23,903 | +8.76% |
| 2010 | 2010-12-31 | $273,014 | — | — |
Skinvisible quarterly total assets
| Fiscal quarter | Period ended | Total assets | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $123,334 | −$20,041 | −13.98% |
| Q1 2026 | 2026-03-31 | $119,419 | −$30,135 | −20.15% |
| Q4 2025 | 2025-12-31 | $127,567 | −$30,650 | −19.37% |
| Q3 2025 | 2025-09-30 | $133,623 | −$15,020 | −10.10% |
| Q2 2025 | 2025-06-30 | $143,375 | −$19,683 | −12.07% |
| Q1 2025 | 2025-03-31 | $149,554 | −$3,849 | −2.51% |
| Q4 2024 | 2024-12-31 | $158,217 | −$4,652 | −2.86% |
| Q3 2024 | 2024-09-30 | $148,643 | −$36,418 | −19.68% |
| Q2 2024 | 2024-06-30 | $163,058 | −$33,261 | −16.94% |
| Q1 2024 | 2024-03-31 | $153,403 | −$52,455 | −25.48% |
| Q4 2023 | 2023-12-31 | $162,869 | −$83,924 | −34.01% |
| Q3 2023 | 2023-09-30 | $185,061 | −$94,097 | −33.71% |
| Q2 2023 | 2023-06-30 | $196,319 | −$124,271 | −38.76% |
| Q1 2023 | 2023-03-31 | $205,858 | $22,270 | +12.13% |
| Q4 2022 | 2022-12-31 | $246,793 | $19,494 | +8.58% |
| Q3 2022 | 2022-09-30 | $279,158 | $63,387 | +29.38% |
| Q2 2022 | 2022-06-30 | $320,590 | $89,792 | +38.91% |
| Q1 2022 | 2022-03-31 | $183,588 | $14,842 | +8.80% |
| Q4 2021 | 2021-12-31 | $227,299 | $27,055 | +13.51% |
| Q3 2021 | 2021-09-30 | $215,771 | $31,675 | +17.21% |
| Q2 2021 | 2021-06-30 | $230,798 | $14,233 | +6.57% |
| Q1 2021 | 2021-03-31 | $168,746 | −$6,027 | −3.45% |
| Q4 2020 | 2020-12-31 | $200,244 | $18,482 | +10.17% |
| Q3 2020 | 2020-09-30 | $184,096 | −$23,982 | −11.53% |
| Q2 2020 | 2020-06-30 | $216,565 | $5,418 | +2.57% |
| Q1 2020 | 2020-03-31 | $174,773 | −$29,678 | −14.52% |
| Q4 2019 | 2019-12-31 | $181,762 | −$38,626 | −17.53% |
| Q3 2019 | 2019-09-30 | $208,078 | −$19,998 | −8.77% |
| Q2 2019 | 2019-06-30 | $211,147 | −$184,199 | −46.59% |
| Q1 2019 | 2019-03-31 | $204,451 | −$221,575 | −52.01% |
| Q4 2018 | 2018-12-31 | $220,388 | −$411,801 | −65.14% |
| Q3 2018 | 2018-09-30 | $228,076 | −$362,348 | −61.37% |
| Q2 2018 | 2018-06-30 | $395,346 | −$135,194 | −25.48% |
| Q1 2018 | 2018-03-31 | $426,026 | $104,192 | +32.37% |
| Q4 2017 | 2017-12-31 | $632,189 | $292,592 | +86.16% |
| Q3 2017 | 2017-09-30 | $590,424 | $239,722 | +68.35% |
| Q2 2017 | 2017-06-30 | $530,540 | $159,914 | +43.15% |
| Q1 2017 | 2017-03-31 | $321,834 | −$62,592 | −16.28% |
| Q4 2016 | 2016-12-31 | $339,597 | −$60,933 | −15.21% |
| Q3 2016 | 2016-09-30 | $350,702 | −$65,071 | −15.65% |
| Q2 2016 | 2016-06-30 | $370,626 | −$103,314 | −21.80% |
| Q1 2016 | 2016-03-31 | $384,426 | −$117,511 | −23.41% |
| Q4 2015 | 2015-12-31 | $400,530 | −$245,524 | −38.00% |
| Q3 2015 | 2015-09-30 | $415,773 | −$259,414 | −38.42% |
| Q2 2015 | 2015-06-30 | $473,940 | −$17,914 | −3.64% |
| Q1 2015 | 2015-03-31 | $501,937 | −$186,047 | −27.04% |
| Q4 2014 | 2014-12-31 | $646,054 | −$227,997 | −26.09% |
| Q3 2014 | 2014-09-30 | $675,187 | −$423,349 | −38.54% |
| Q2 2014 | 2014-06-30 | $491,854 | −$244,084 | −33.17% |
| Q1 2014 | 2014-03-31 | $687,984 | $198,157 | +40.45% |
| Q4 2013 | 2013-12-31 | $874,051 | $119,804 | +15.88% |
| Q3 2013 | 2013-09-30 | $1.1M | $714,065 | +185.73% |
| Q2 2013 | 2013-06-30 | $735,938 | $377,859 | +105.52% |
| Q1 2013 | 2013-03-31 | $489,827 | $154,454 | +46.05% |
| Q4 2012 | 2012-12-31 | $754,247 | $457,330 | +154.03% |
| Q3 2012 | 2012-09-30 | $384,471 | −$147,141 | −27.68% |
| Q2 2012 | 2012-06-30 | $358,079 | −$174,372 | −32.75% |
| Q1 2012 | 2012-03-31 | $335,373 | — | — |
| Q4 2011 | 2011-12-31 | $296,917 | $23,903 | +8.76% |
| Q3 2011 | 2011-09-30 | $531,612 | — | — |
| Q2 2011 | 2011-06-30 | $532,451 | — | — |
| Q4 2010 | 2010-12-31 | $273,014 | — | — |
Skinvisible total assets trends
Over the last five fiscal years, Skinvisible's total assets decreased from $200,244 to $127,567, a change of −$72,677. The latest reported quarter, Q2 2026, shows $123,334.
What total assets mean
Total assets are the resources a company controls at a reporting-period end, including cash, investments, receivables, inventory, property, intangible assets, and other reported assets. The composition of assets differs substantially by industry.
SEC-reported total assets
TickerStat uses total assets reported in company SEC filings. When a filer provides the equivalent balance-sheet total as liabilities and equity, that reported amount is used because total assets must equal total liabilities plus equity. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Skinvisible source filings ↗